Introduction
Inhibin, a disulphide-linked heterodimer which preferentially suppresses FSH secretion, has been purified from several species and its amino acid sequence deduced by recombinant DNA methods (for reviews, see de Jong, 1988; Ying, 1988; de Kretser & Robertson, 1989) . However, the isolation of inhibin from human sources (e.g. follicular fluid) has not been possible owing to limited avail¬ ability and low inhibin concentrations (McLachlan et ai, 1986; Robertson et ai, 1990) . There is a paucity of information concerning the actions of purified inhibin preparations in vivo due to the small yields. In a previous study, bovine inhibin of M, 31 000 was shown to suppress serum FSH to 69% of control with a nadir occurring at 4-8 h (Findlay et ai, 1987) .
Human inhibin A has been produced by recombinant DNA methods, purified and charac¬ terized (Tierney et ai, 1990) . It consists of two subunits (a and ßA) in two molecular weight forms (31 000 and 34 000). Both forms are similar based on a number of physicochemical character¬ istics with the difference in molecular weight attributed to differences in glycosylation. Both are biologically active in vitro but their biological activities in vivo have not yet been established.
The aim of this study was to establish the in-vivo biological activity of human recombinant inhibin A (hr-inhibin) by assessing its effects on serum FSH and LH concentrations of male and female rats and to obtain information concerning its duration of action. 2, 4, 6, 8, 16 or 24 h (hr-inhibin).
For the inhibin dose-response study, rats (5-8/group) were injected with bFF (31-25-500 pi/100 g body wt), hr-inhibin (0-625^0 pg/100 g body wt) or solvent (500 pl/100 g body wt) and killed 5 h later.
Female rats. To study the inhibin dose-response female rats (81-85 days of age, 220 ± 30 g) were ovariectomized under ether anaesthesia. After 2 days, the rats (6-7/group) were injected i.p. with bFF (125-500 pi) or hr-inhibin (2-5-20 pg) and killed 8 h later. Trunk blood was collected and serum stored at -20°C.
Assays. Serum rat FSH and LH concentrations were determined using radioimmunoassay reagents provided by the NIADDK, Bethesda, MD, USA. FSH was assayed utilizing iodinated rat FSH (NIADDK rFSH-I5 or -17) as tracer, rat FSH antiserum (NIADDK anti-rFSH-Sl 1 (male rat study) or an in-house antiserum in the female rat study (Gibson el ai, 1979) ) and rFSH-RP-2 as standard. The within-and between-assay variations were <5% and < 10% respectively. The sensitivity was 3 ng/ml.
LH was assayed utilizing iodinated rat LH (NIADDK rLH-I7) as tracer, rat LH antiserum (NIADDK anti-rLH-S9 or SI0) and rLH-RP2 as standard. The within-and between-assay variations were <7% and < 10%, respectively. All samples from one experiment were assayed in the one assay. Sensitivity was 2 ng/ml.
The inhibin in-vitro bioassay method of Scott et ai (1980) was used with an in-house bFF preparation (bFF2/4) calibrated in terms of a previously described (Scott et ai, 1980) ovine testicular lymph preparation as standard. In terms of the WHO pig inhibin reference preparation (86/690), one unit of the bFF standard was equivalent to 25 9 ± 0-80 units of 86/690. Sensitivity was 00625 U/ml. I 0-4 Fig. 1 . Time-course effects of bovine follicular fluid (bFF) (a, b) and hr-inhibin (c, d) on serum FSH and LH concentrations in 3-day castrated 35-day-old male rats. bFF (lOOpl/lOOg body wt) and hr-inhibin (lOpg/lOOg body wt) were administered i.v. *P < 005, ***P < 0001 compared with control values.
Calculations. All bFF and hr-inhibin dose-response data were standardized asa percentage of control values as a means of comparing assay characteristics between systems. An assessment of regression, linearity, precision and relative potency was performed using in-house computer programs based on the methods of Finney (1971) . When visual evidence of a dose-response effect was observed, potency estimates were determined based on at least 2 doses of bFF standard and 2-3 doses of hr-inhibin with the exception of Exp. 2 in the study of female rats in which the highest dose of the standard only was used. This approach was justified as it was shown in Exp. 1 that the bFF and hr-inhibin dose-response curves were parallel.
Comparisons between groups were performed using the Peritz multiple comparison test for differences among group means (Harper, 1984) .
Results
Time-course effects in male rats A single i.v. injection of bFF and hr-inhibin to 3-day castrated rats resulted in a fall (P < 005-P < 0001) in serum FSH after 4-8 h, returning to reach control FSH concentrations by 16-26 h. No rebound effects of inhibin on FSH were observed. Serum LH concentrations were unaffected (Fig. 1) . OFFRII hr-lnh¡b¡n (µ9) Fig. 2 . Dose-response effects of bFF and hr-inhibin on serum FSH and LH 5 h after adminis¬ tration to 3-day-castrated, 35-day-old male rats. Results of Exps 1 (O) and 2 (·) (see Table  1 ) are presented. */><005, **P < 001, ***P<0-001; t/><005, tt^<0-01, ttt^<0001 compared with control values.
In-vivo dose-response in male rats bFF (31-3-250 pi) and hr-inhibin (0-625-10 pg) administered to 3-day castrated rats resulted in a significant dose-related decline in serum FSH concentrations after 5 h ( Fig. 2; Table 1 ). Higher doses of bFF (500 µ /100 g body wt) and hr-inhibin (20-40 pg/100 g body wt) showed no further suppression below 50% of control values (data not shown). Serum LH concentrations showed no dose-related changes with bFF or hr-inhibin, although isolated differences were observed in one experiment (Fig. 2) .
In-vivo dose-response in female rats Graded doses of bFF (125-500 pi) and hr-inhibin (2-5-20 pg) administered to 2-day ovari¬ ectomized rats resulted in a significant fall in serum FSH to 30% of control values after 8 h, while LH concentrations were unaffected (Fig. 3) .
Analysis of dose-response relationships
To determine the in-vivo biopotency of hr-inhibin, the bFF preparation was assigned an in-vivo biopotency based on its in-vitro activity (Table 1) . Various characteristics of the dose-response curves for bFF and hr-inhibin in the male and female rat systems are summarized in Table 1 . The biopotency of hr-inhibin in terms of bFF in the in-vitro bioassay was 1120 (1040:1210) U/pg protein (weighted mean and 95% fiducial limits). Table 1 ) are presented. *P<005, ***P < 0001, f/'<005, ttt^<0001), compared with controls.
In the male rat system a biopotency of 407 (159:1050) U/pg protein was obtained. The poor precision as assessed by the index of precision is associated with the limited slope of the dose-response line although the regression of the line was significant (P < 0001).
In (Findlay et ai, 1987) . However, the characteristics of the inhibin dose-response effects for both bFF and hrinhibin in the two sexes differ. The limited suppressive effect of bFF on serum FSH concentrations in male, compared with female, rats has been reported previously (de Jong et ai, 1979) . The basis for this limited suppression is unknown although the degree of suppression also differs at different ages. For example, a more marked suppression was observed with castrated 15-day-old rats than for castrated 75-day-old rats (de Jong et ai, 1979) . One possible explanation involving the role of testosterone arises from passive immunization studies with inhibin-neutralizing antisera in adult male rats treated with the cytotoxin, ethane dimethane sulphonate (EDS: Culler & Negro-Vilar, 1988; Culler, 1989) . EDS selectively destroys Leydig cells, resulting in a dramatic fall in testosterone production. In these studies, passive immunization of adult control animals failed to result in a rise of serum FSH, while causing a rise of serum FSH in EDS-treated or immature male rats. These findings suggest that testosterone antagonizes the inhibitory effects of inhibin on FSH secretion and may explain the failure to observe a complete suppression of serum FSH in castrated rats in the present study.
No significant dose-related changes in serum LH concentrations were observed with bFF or hr-inhibin in this study. It is known that LH secretion in the rat is markedly episodic (Steiner et ai, 1982) and so single blood samples from rats, as in this study, will result in large within-group errors in LH measurements. While inhibin has limited effects on basal secretion of LH in vitro (Farnworth et ai, 1988a) , it does have suppressive effects on the GnRH-stimulated LH secretion in vitro (Farnworth et ai, 1988b) .
The in-vitro (1120 U/pg) and in-vivo (367 U/pg) biopotencies of hr-inhibin are reasonably comparable considering the variables involved in the determinations. First, the standard used was a follicular fluid preparation from a different species (bovine). Second, the predominant inhibin forms in bFF are larger (Mr >58 000 inhibin; Miyamoto et ai, 1986; Robertson et ai, 1986) and so may exhibit different biological responses in vivo (e.g. a longer circulating half-life) than the hr-inhibin of Mr 30 000-34 000 although bovine inhibins of Mr 31 000 and 58 000 have been shown to exhibit similar in-vitro potencies (Robertson et ai, 1986) . Thirdly, other activities (activin, FSH-suppressing protein/follistatin; for reviews see de Jong, 1988; Ying, 1988; de Kretser & Robertson, 1989) have been identified in bFF which may contribute to the difference in potency estimate, although their contributions are likely to be small. Potency differences of this magnitude between in-vivo and in-vitro activities have been observed previously with human gonadotrophins (Storring & Gaines Das, 1989) .
The female rat system provides a good basis for an inhibin in-vivo bioassay as originally proposed by de Jong et al. (1979) . The working range is relatively large (2-5-20 pg hr-inhibin) with a maximum suppression to at least 30% of control values with a reasonably steep slope to give acceptable precision indices (0-2). This system is less sensitive (2-5 pg) than that observed in the male (< 0-625 pg) and may relate to the mode of delivery (i.p. vs i.v.) and age of animal. To make this system more practical a shorter time interval, e.g. 5 h, is required. On the other hand, the male rat system is too imprecise to use as an in-vivo assay system due to the shallow slope of the doseresponse curve, resulting in high indices of precision and very large fiducial limits. The index of precision values (0-6-0-7) are not considered acceptable in parallel line assay systems; however, while the potency values are imprecise, they are broadly similar to those obtained with the female rat system, suggesting that the inhibin responses are similar in both sexes.
In conclusion, these studies have shown that hr-inhibin exhibits FSH-suppressing activity simi¬ lar to that seen with bFF and purified native bovine inhibin. The similar in-vivo pattern of response of hr-inhibin and bFF and their similar relative activities both in vivo and in vitro indicates that hr-inhibin can be used to explore the physiology of inhibin in vivo.
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